Username Password
S&P 500: 1,348.81 Change: +0.37%

RESPONSE GENETICS INC (RGDX)

Overview
Price 1.72
Price Change Today -$0.03 (-1.71%)
P&P rating Rating: 0
Zacks Rank 3 - HOLD
Open Price $1.71
Previous Close $1.75
Daily Range $1.71 - $1.94
52-Week Range $0.81 - $3.05
Volume 92,659
chart
Response Genetics, Inc. is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens. RGI currently generates revenue primarily from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry.
Other Resources for RGDX
zacks.com
Commentary
No Commentary Found for This Ticker.
Response Genetics, Inc. is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens. RGI currently generates revenue primarily from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry.
 
Brokerage Analyst Recommendations
1 Brokerage Firms Covering RGDX
 
 
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 3
 
RGDX Ratings:BUY  SELL  HOLD
RGDX Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

0 Buy
0 Sell
 
Top Buy Analysis
No Buy Analysis. Be the First.

Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
No related Blog Posts.
Commentary
There are no open picks with this stock at the moment.
Picks
There are no open picks with this stock at the moment.
Sponsored Links